- HK$552.91m
- -HK$598.99m
- CNY601.39m
Annual balance sheet for Yunkang, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 801 | 1,430 | 1,871 | 1,734 | 1,704 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 853 | 2,546 | 1,537 | 641 | 349 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,743 | 4,168 | 3,838 | 2,659 | 2,217 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 485 | 421 | 397 | 314 | 258 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,455 | 4,907 | 4,532 | 3,228 | 2,735 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 871 | 1,979 | 2,189 | 1,916 | 1,393 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,004 | 2,375 | 2,420 | 2,085 | 1,580 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 1,452 | 2,532 | 2,112 | 1,144 | 1,155 |
| Total Liabilities & Shareholders' Equity | 2,455 | 4,907 | 4,532 | 3,228 | 2,735 |
| Total Common Shares Outstanding |